Higher dose Wegovy demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity
Early responders (15% or more weight loss after 24 weeks) to the higher dose of Wegovy®️ (semaglutide 7.2 mg) achieved on average 27.7% mean weight loss at week 72 in…
